mailed
on 25 Nov 2024
Last Applicant/ Owned by
4 Maguire Road
Lexington
MA
02421
Serial Number
97761243 filed on 19th Jan 2023
Registration Number
N/A
Correspondent Address
Christina M. Licursi, Esq.
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
4. use application currently
Disclaimer
NO DATA
Medical and scientific research in the field of cell therapies, biotechnology, and drug development; providing medical and scientific research information; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields Read More
Medical and scientific research in the field of cell therapies, biotechnology, and drug development; providing medical and scientific research information; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields
02th Oct 2017
02th Oct 2017
Pharmaceuticals for use in the treatment of cancer and autoimmune disease containing small molecules; cells for medical use; pharmaceuticals for use in the treatment of cancer and autoimmune disease
N/A
N/A
Small molecules for scientific and research use; cells for scientific and research use
N/A
N/A
No 97761243
No Service Mark
No K07132000301
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Nov 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
25th Nov 2024 | FINAL REFUSAL E-MAILED |
25th Nov 2024 | FINAL REFUSAL WRITTEN |
01st Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
30th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
30th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
01st Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
01st Jul 2024 | NON-FINAL ACTION WRITTEN |
01st Jul 2024 | NON-FINAL ACTION E-MAILED |
25th Apr 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |